- Home
- INKT vs WVVI Comparison
INKT vs WVVI Comparison
Compare INKT & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- WVVI
- Stock Information
- Founded
- INKT 2017
- WVVI 1983
- Country
- INKT United States
- WVVI United States
- Employees
- INKT N/A
- WVVI N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- WVVI Beverages (Production/Distribution)
- Sector
- INKT Health Care
- WVVI Consumer Staples
- Exchange
- INKT Nasdaq
- WVVI Nasdaq
- Market Cap
- INKT 28.8M
- WVVI 28.2M
- IPO Year
- INKT 2021
- WVVI N/A
- Fundamental
- Price
- INKT $28.86
- WVVI $4.94
- Analyst Decision
- INKT Hold
- WVVI
- Analyst Count
- INKT 3
- WVVI 0
- Target Price
- INKT $37.50
- WVVI N/A
- AVG Volume (30 Days)
- INKT 2.7M
- WVVI 26.0K
- Earning Date
- INKT 08-12-2025
- WVVI 08-12-2025
- Dividend Yield
- INKT N/A
- WVVI N/A
- EPS Growth
- INKT N/A
- WVVI N/A
- EPS
- INKT N/A
- WVVI N/A
- Revenue
- INKT N/A
- WVVI $38,520,945.00
- Revenue This Year
- INKT N/A
- WVVI N/A
- Revenue Next Year
- INKT N/A
- WVVI N/A
- P/E Ratio
- INKT N/A
- WVVI N/A
- Revenue Growth
- INKT N/A
- WVVI N/A
- 52 Week Low
- INKT $4.56
- WVVI $3.17
- 52 Week High
- INKT $76.00
- WVVI $7.18
- Technical
- Relative Strength Index (RSI)
- INKT 60.80
- WVVI 32.67
- Support Level
- INKT $6.80
- WVVI $5.21
- Resistance Level
- INKT $76.00
- WVVI $5.75
- Average True Range (ATR)
- INKT 5.95
- WVVI 0.30
- MACD
- INKT 3.73
- WVVI -0.02
- Stochastic Oscillator
- INKT 35.31
- WVVI 31.65
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.